Sterile Lap Sponges Sales

Sterile Lap Sponges Sales Market Outlook

The global sterile lap sponges market is projected to reach approximately USD 1.2 billion by 2035, with a compound annual growth rate (CAGR) of around 6.5% during the forecast period of 2025-2035. The growth of this market can be attributed to the increasing number of surgical procedures being performed worldwide, driven by the rising prevalence of chronic diseases and injuries that necessitate surgical interventions. Additionally, the growing awareness of infection control practices and the high demand for sterilized surgical supplies in healthcare settings are further propelling the growth of the sterile lap sponges market. The expansion of healthcare infrastructure in developing regions and improvements in healthcare policies also play a vital role in this upward trend. Furthermore, technological advancements in the manufacturing processes of surgical supplies have led to the development of innovative products that cater to the evolving needs of medical practitioners and patients alike.

Growth Factor of the Market

One of the key growth factors for the sterile lap sponges market is the increasing number of surgical procedures across various medical fields, including general surgery, orthopedics, and gynecology. As hospitals and surgical centers perform more surgeries, the demand for high-quality, sterile items such as lap sponges continues to rise. Additionally, the growing trend of outpatient surgeries in ambulatory surgical centers necessitates the use of efficient, sterile supplies, driving the market further. Another contributing factor is the heightened focus on infection prevention and control measures, as healthcare authorities and institutions strive to minimize the risk of surgical site infections (SSIs). This has led to an increased emphasis on acquiring sterile, reliable surgical materials that meet stringent regulatory standards. The expansion of healthcare services in emerging markets, where surgical procedures are on the rise due to improving economic conditions, also contributes significantly to market growth. Lastly, the introduction of innovative lap sponge products that integrate advanced materials and technologies has enhanced their usability and effectiveness in surgical settings, catering to a broader range of applications.

Key Highlights of the Market

• The sterile lap sponges market is poised for robust growth, projected to reach USD 1.2 billion by 2035.
• The increasing prevalence of chronic diseases necessitating surgical interventions is a key growth driver.
• Heightened infection control measures in healthcare settings are propelling demand for sterile surgical supplies.
• The expansion of healthcare infrastructure in developing regions is further supporting market growth.
• Technological innovations in manufacturing processes are improving product quality and efficacy.

By Product Type

X-ray detectable lap sponges:

X-ray detectable lap sponges represent a significant segment within the sterile lap sponges market, primarily due to their critical role in preventing retained surgical items, a serious complication associated with surgical procedures. These sponges contain radiopaque materials that allow them to be detected on X-ray imaging, ensuring that no sponges are left in the patient's body post-operation. This feature significantly enhances patient safety and is increasingly mandated by healthcare regulations. As hospitals and surgical centers prioritize minimizing surgical errors and improving patient outcomes, the demand for X-ray detectable lap sponges is expected to grow steadily. Furthermore, with the rising awareness of patient safety protocols and the implementation of stringent surgical site checklists, the uptake of these specialized sponges is anticipated to increase across various healthcare facilities.

Non X-ray detectable lap sponges:

Non X-ray detectable lap sponges also hold a substantial share in the market, primarily due to their cost-effectiveness and widespread availability. These sponges are designed for various surgical applications, particularly in situations where X-ray detection is not deemed necessary. Despite lacking the X-ray detection feature, non X-ray detectable lap sponges are still highly effective in absorbing fluids and providing the necessary support during surgical procedures. They are commonly used in less invasive surgeries and minor procedures, making them a preferred choice for many healthcare facilities focused on cost management. As the volume of outpatient surgeries continues to rise, the demand for non X-ray detectable lap sponges is expected to remain robust, especially in clinics and ambulatory surgical centers that prioritize budget-friendly options without compromising quality.

Pre-washed lap sponges:

Pre-washed lap sponges are gaining popularity in the sterile lap sponges market as they offer convenience and efficiency to surgical teams. These sponges are pre-washed and sterilized, allowing for immediate use during procedures without the need for additional preparation. The convenience of having ready-to-use sponges enhances surgical workflow and minimizes the time taken to set up instruments and supplies before operations. Moreover, pre-washed lap sponges are available in various sizes and absorbent capacities, making them adaptable to different surgical needs. As the emphasis on operational efficiency and quick turnaround times in surgical settings increases, the demand for pre-washed lap sponges is likely to grow, particularly among hospitals and surgical centers aiming to improve productivity.

Dry lap sponges:

Dry lap sponges are another essential product in the sterile lap sponges market, primarily utilized in surgical settings where absorption is needed but wetness or moisture could hinder the procedure. These sponges are often preferred in various surgical fields, including orthopedic and general surgery, where a dry environment is crucial for the successful completion of the operation. Their porous structure allows for effective fluid absorption while maintaining a dry surface, which helps in maintaining the surgical field's integrity. As surgical techniques advance and the need for specialized products increases, the adoption of dry lap sponges is expected to rise, particularly in facilities that emphasize best practices in surgical care.

Others:

The 'Others' category encompasses a range of niche products and innovations in the sterile lap sponges market, including specialized sponges tailored for unique surgical applications and procedures. This segment may include sponges designed for specific surgical disciplines, such as neurosurgery or cardiovascular surgery, where unique material properties or designs are required to accommodate different surgical environments. The continuous development of these specialized products indicates a trend towards customization and tailored solutions in the medical supply industry, providing healthcare professionals with the tools they need to achieve optimal surgical outcomes. As more healthcare facilities adopt bespoke surgical products that meet their unique requirements, this segment is likely to experience significant growth and diversification.

By Application

Hospitals:

Hospitals constitute a major application segment in the sterile lap sponges market, as they are the primary setting for a wide array of surgical procedures. The demand for sterile lap sponges in hospitals is driven by the high volume of surgeries performed daily, ranging from elective to emergency procedures. Hospitals are increasingly adopting stringent infection control protocols, which necessitate the use of high-quality, sterile surgical materials to minimize the risk of surgical site infections. This has led to the incorporation of various types of lap sponges in surgical kits, with a focus on sponges that offer reliability and efficiency. As the frequency of surgical interventions continues to rise globally, hospitals will remain a significant driver of growth in this market segment.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are emerging as a critical application segment for the sterile lap sponges market, owing to their increasing popularity for outpatient procedures. ASCs provide cost-effective solutions for patients requiring minor surgical interventions, facilitating a more efficient healthcare delivery model. The demand for sterile lap sponges in these facilities is influenced by the need for quick turnaround times and high-quality surgical supplies that meet regulatory standards. As the trend toward outpatient surgeries grows, the utilization of sterile lap sponges tailored for specific outpatient procedures is expected to rise, making ASCs a vital market for sterile lap sponge manufacturers.

Clinics:

Clinics, especially those specializing in minor surgical procedures, are another significant application segment in the sterile lap sponges market. These healthcare facilities often perform a variety of minimally invasive procedures that require reliable and sterile materials. Given the lower volume of surgeries compared to hospitals, clinics tend to prioritize cost-effectiveness while ensuring quality in the surgical supplies they procure. Sterile lap sponges are integral to their surgical kits, serving to manage fluid absorption effectively. As clinics increasingly adopt best practices in infection control and enhance their surgical capabilities, the demand for sterile lap sponges is anticipated to grow, further solidifying their importance in the healthcare landscape.

Others:

The 'Others' category encompasses various unique applications for sterile lap sponges, including specialty clinics and surgical centers that focus on specific areas of medicine, such as dermatology or plastic surgery. These facilities often require specialized surgical supplies that cater to their unique procedural needs. The demand for sterile lap sponges in this category is driven by the increasing focus on patient safety and surgical outcomes across diverse healthcare settings. Manufacturers are likely to innovate and create tailored solutions that meet the specific requirements of these specialized applications, contributing to the overall growth of the sterile lap sponges market.

By Distribution Channel

Direct Sales:

Direct sales are a crucial distribution channel in the sterile lap sponges market, allowing manufacturers to engage directly with healthcare providers and facilities. This channel enables manufacturers to build strong relationships with hospitals, surgical centers, and clinics, fostering trust and reliability in their products. Direct sales also facilitate better understanding of customer requirements, leading to tailored solutions that enhance customer satisfaction. As healthcare providers continue to seek reliable and efficient surgical supplies, the demand for direct sales channels is expected to rise, allowing manufacturers to maintain a competitive edge. Additionally, the direct sales approach often involves providing training and support to healthcare professionals, further strengthening partnerships and improving the end-user experience.

Distributors:

Distributors play a vital role in the sterile lap sponges market, serving as intermediaries that provide a wide range of surgical supplies to healthcare facilities. These distributors often stock a diverse selection of products, allowing healthcare providers to source all their surgical needs from a single supplier. The advantage of using distribution channels lies in their ability to streamline the procurement process for healthcare facilities, offering timely deliveries and consistent availability of products. As the demand for sterile lap sponges continues to grow, distributors are likely to expand their offerings and improve their supply chain efficiency, ensuring that healthcare providers have access to the necessary surgical supplies for their procedures.

By Material Type

Cotton lap sponges:

Cotton lap sponges are a traditional staple within the sterile lap sponges market, known for their exceptional absorbency and softness. These sponges are widely used in surgical procedures for their ability to manage blood and other fluids effectively, ensuring a clean surgical field. Cotton lap sponges are favored for their biocompatibility and comfort, making them a preferred choice among surgeons and medical practitioners. Furthermore, cotton sponges are easy to handle and can be made in various sizes to suit different surgical applications. The rising demand for cotton lap sponges is expected to persist as healthcare facilities prioritize reliable and effective solutions for fluid management during surgeries.

Synthetic lap sponges:

Synthetic lap sponges are gaining traction in the sterile lap sponges market due to their unique properties that enhance surgical performance. Made from materials such as polyester or polyamide, synthetic sponges often offer superior absorbency, durability, and resistance to fraying compared to traditional cotton sponges. These sponges are designed for specific applications where enhanced performance is needed, including surgeries that involve extensive fluid management. As surgeons seek out innovative materials to improve surgical outcomes, the demand for synthetic lap sponges is expected to grow, particularly in specialized surgical procedures that require advanced solutions.

Blend lap sponges:

Blend lap sponges, which combine different materials such as cotton and synthetic fibers, are becoming increasingly popular in the sterile lap sponges market. These sponges offer the benefits of both cotton's softness and absorbency and the resilience and strength of synthetic materials. As a result, blend lap sponges provide enhanced performance in various surgical scenarios, making them versatile tools for surgeons. The trend toward using blended materials reflects the evolving needs of the surgical field, where practitioners are looking for sponges that can adapt to different surgical environments while ensuring effective fluid management. The demand for blend lap sponges is anticipated to rise as healthcare providers seek innovative solutions that optimize surgical performance.

Others:

The 'Others' category in material types includes specialty lap sponges designed for specific medical applications or procedures. This may involve unique materials or advanced manufacturing techniques tailored for niche surgical environments, such as minimally invasive surgeries or specialty procedures like laparoscopies. Products under this category may incorporate materials that offer specific benefits, such as enhanced fluid management or bio-active properties to promote healing. As surgical techniques advance and the demand for specialized supplies grows, this segment is likely to see significant innovation and expansion, catering to the diverse needs of healthcare providers and improving patient outcomes.

By Region

North America dominates the sterile lap sponges market, accounting for a substantial share of the global revenue. The region's dominance can be attributed to the well-established healthcare infrastructure, a high volume of surgical procedures performed annually, and a strong emphasis on patient safety and infection control protocols. The growing prevalence of chronic diseases and the increasing number of outpatient surgical procedures have further fueled the demand for sterile lap sponges in this region. According to industry estimates, the North American market is expected to grow at a CAGR of around 5.8% from 2025 to 2035, reflecting the ongoing developments in surgical practices and the healthcare sector's commitment to safety and quality.

Europe follows closely as a key player in the sterile lap sponges market, driven by a robust healthcare system and a high rate of surgical interventions. Countries such as Germany, France, and the UK are at the forefront, consistently investing in advanced medical technologies and enhancing their healthcare facilities. The emphasis on reducing surgical site infections and improving patient outcomes is propelling the demand for high-quality sterile supplies, including lap sponges. The European market is expected to witness steady growth, supported by ongoing advancements in surgical techniques and materials, as well as increased collaborations between medical device manufacturers and healthcare providers.

Opportunities

The sterile lap sponges market presents numerous opportunities for growth driven by the increasing awareness of infection control practices among healthcare providers. As hospitals and surgical centers continue to prioritize patient safety and strive to minimize the risk of surgical site infections, the demand for high-quality, sterile surgical supplies, including lap sponges, is expected to rise. This shift towards a more infection-conscious healthcare environment opens avenues for manufacturers to innovate and develop advanced sponge products that cater to these evolving demands. Moreover, the expansion of healthcare facilities in emerging markets signals a growing need for surgical supplies, creating significant market opportunities for key players looking to establish their presence in these regions. Investments in local production facilities could also enhance supply chain efficiencies and reduce lead times for hospitals and clinics seeking reliable sourcing options.

Additionally, there is an opportunity for manufacturers to explore partnerships and collaborations with healthcare institutions to better understand their needs and tailor products accordingly. By engaging with healthcare providers, manufacturers can identify specific areas where innovation is required, leading to the development of specialized sponges that meet unique surgical requirements. Furthermore, educational initiatives focused on highlighting the importance of sterile supplies in preventing infections can stimulate demand. As healthcare facilities recognize the value of investing in quality surgical materials, the overall sterile lap sponges market is poised for positive growth, driven by ongoing advancements in product offerings and a stronger focus on patient outcomes.

Threats

While the sterile lap sponges market shows promising growth prospects, it also faces several threats that may hinder its expansion. One significant concern is the rising competition among manufacturers, which can lead to price wars and reduced profit margins. As more companies enter the market, particularly in emerging regions, the oversaturation could result in intense rivalry, forcing manufacturers to compromise on quality or service to maintain market share. Additionally, fluctuations in raw material prices may impact production costs, further challenging manufacturers to balance quality and affordability. As the surgical supply industry becomes more competitive, maintaining product differentiation and ensuring a strong brand reputation will be crucial for long-term success.

Another potential threat to the market relates to regulatory challenges and compliance issues. The sterile lap sponges market is subject to stringent regulatory standards imposed by health authorities to ensure product safety and efficacy. Compliance with these regulations can be time-consuming and costly for manufacturers, especially for small and medium-sized enterprises. Failure to meet compliance requirements could result in product recalls, legal liabilities, and damage to brand reputation, undermining consumer trust. Furthermore, the ongoing evolution of surgical techniques and the development of alternative materials may lead to changes in market dynamics, requiring manufacturers to stay agile and adapt to shifting trends to remain competitive.

Competitor Outlook

• 3M Company
• Medtronic Plc
• Cardinal Health, Inc.
• Johnson & Johnson
• B. Braun Melsungen AG
• Smith & Nephew Plc
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• ConvaTec Group Plc
• Ethicon, Inc. (a subsidiary of Johnson & Johnson)
• Covidien Ltd. (a subsidiary of Medtronic Plc)
• Medline Industries, Inc.
• Owens & Minor, Inc.
• Wound Care Technologies, Inc.
• Huntleigh Healthcare Ltd.

The competitive landscape of the sterile lap sponges market is characterized by the presence of several well-established players, as well as emerging companies striving to make their mark in the industry. These companies are focusing on product innovation, strategic partnerships, and market expansion efforts to enhance their share in this growing market. Key strategies employed by leading players include investing in research and development to develop advanced materials and technologies that improve the efficacy of lap sponges. Additionally, companies are enhancing their distribution networks to ensure timely availability of products to healthcare providers, thereby fostering customer loyalty and satisfaction. The competitive dynamics in this market are also influenced by mergers and acquisitions, as companies seek to strengthen their market position and broaden their product portfolios.

Major companies in the sterile lap sponges market, such as 3M Company and Medtronic Plc, have established themselves as leaders by offering a diverse range of surgical supplies and investing in innovative product development. For instance, 3M has developed a strong portfolio of infection prevention products, including advanced lap sponges designed for optimal fluid management and patient safety. Similarly, Medtronic has a comprehensive range of surgical solutions, emphasizing the importance of quality and reliability in surgical procedures. These companies leverage their extensive research capabilities and industry expertise to continuously enhance their offerings and meet the evolving needs of healthcare providers.

Other notable players in the market, like Johnson & Johnson and Cardinal Health, have also made significant strides in advancing surgical supplies that prioritize patient safety. Johnson & Johnson, through its subsidiary Ethicon, has cultivated a reputation for producing high-quality sterile products, ensuring their lap sponges meet rigorous safety standards. Cardinal Health, on the other hand, focuses on providing comprehensive medical supply solutions, offering a wide array of lap sponges that cater to various surgical settings. Both companies are committed to enhancing their product offerings and exploring new market opportunities to maintain a competitive edge in the evolving landscape.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic Plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Johnson & Johnson
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 ConvaTec Group Plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Smith & Nephew Plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Owens & Minor, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 B. Braun Melsungen AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cardinal Health, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Hollister Incorporated
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Huntleigh Healthcare Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Wound Care Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Integra LifeSciences Holdings Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Covidien Ltd. (a subsidiary of Medtronic Plc)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ethicon, Inc. (a subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Sterile Lap Sponges Sales Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Ambulatory Surgical Centers
    • 6.1.3 Clinics
    • 6.1.4 Others
  • 6.2 Sterile Lap Sponges Sales Market, By Product Type
    • 6.2.1 X-ray detectable lap sponges
    • 6.2.2 Non X-ray detectable lap sponges
    • 6.2.3 Pre-washed lap sponges
    • 6.2.4 Dry lap sponges
    • 6.2.5 Others
  • 6.3 Sterile Lap Sponges Sales Market, By Material Type
    • 6.3.1 Cotton lap sponges
    • 6.3.2 Synthetic lap sponges
    • 6.3.3 Blend lap sponges
    • 6.3.4 Others
  • 6.4 Sterile Lap Sponges Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributors

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Sterile Lap Sponges Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Sterile Lap Sponges Sales market is categorized based on

By Product Type

• X-ray detectable lap sponges
• Non X-ray detectable lap sponges
• Pre-washed lap sponges
• Dry lap sponges
• Others

By Application

• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Others

By Distribution Channel

• Direct Sales
• Distributors

By Material Type

• Cotton lap sponges
• Synthetic lap sponges
• Blend lap sponges
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Medtronic Plc
• Cardinal Health, Inc.
• Johnson & Johnson
• B. Braun Melsungen AG
• Smith & Nephew Plc
• Hollister Incorporated
• Integra LifeSciences Holdings Corporation
• ConvaTec Group Plc
• Ethicon, Inc. (a subsidiary of Johnson & Johnson)
• Covidien Ltd. (a subsidiary of Medtronic Plc)
• Medline Industries, Inc.
• Owens & Minor, Inc.
• Wound Care Technologies, Inc.
• Huntleigh Healthcare Ltd.